Provenienza dei contatti di primo grado di John M. Stewart
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
ApopLogic Pharmaceuticals, Inc.
 ApopLogic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ApopLogic Pharmaceuticals, Inc. researches and develops pharmaceutical products. It focuses on the development and commercialization of B201, is a rationally-designed synthetic peptide dimer of a potent decapeptide bradykinin B1&B2 receptor antagonist that directly induces apoptosis of cancer cells that overexpress these receptors and AP-300 is used in the neo-adjuvant or adjuvant setting with standard-of-care agents to improve survival outcomes in humans and companion animals with any accessible solid tumor including carcinomas, sarcomas and lymphomas. The company was founded in 2006 by Richard C. Duke, Donald Bellgrau, Paul A. Bunn, Daniel Chan, Lajos Gera, Jaime F. Modiano and John M. Stewart and is headquartered in Aurora, CO.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a John M. Stewart tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| GLOBEIMMUNE, INC. | Pharmaceuticals: Other | Founder Founder | |
MenoGenix, Inc.
 MenoGenix, Inc. BiotechnologyHealth Technology MenoGenix, Inc. operates as a biotechnology company. It focuses on development of drugs for menopause and the menopause diseases. The company was founded by Debra M. Duke and Jonathan Kaufman in 2010 and is headquartered in Aurora, CO. | Biotechnology | Chief Executive Officer | |
| University of Pennsylvania | College/University | Doctorate Degree Doctorate Degree | |
| McGill University | College/University | Undergraduate Degree | |
| Amherst College | College/University | Undergraduate Degree | |
| Texas A&M University | College/University | Corporate Officer/Principal | |
| University of Colorado Health Sciences Center | College/University | Corporate Officer/Principal | |
| The University of Colorado | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | President | |
| Basel Institute for Immunology | College/University | Corporate Officer/Principal | |
| International Association for the Study of Lung Cancer | Chief Executive Officer | ||
| Weill Cornell Medical College | College/University | Doctorate Degree | |
| AMC Cancer Research Center | Corporate Officer/Principal | ||
Association of American Cancer Institutes
 Association of American Cancer Institutes Miscellaneous Commercial ServicesCommercial Services Association of American Cancer Institutes operates as a membership association of academic and freestanding cancer research centers in the United States. It comprises 98 cancer research centers. The company is headquartered in Pittsburgh, PA. | Miscellaneous Commercial Services | President | |
| VERASTEM, INC. | Biotechnology | Director/Board Member | |
| El Colegio de México AC | College/University | Undergraduate Degree | |
Colorado Institute For Drug Device & Diagnostic Development
 Colorado Institute For Drug Device & Diagnostic Development Medical/Nursing ServicesHealth Services The Colorado Institute For Drug Device & Diagnostic Development provides health maintenance services. The American company was founded by Richard C. Duke. | Medical/Nursing Services | Founder | |
| The University of Colorado School of Medicine | College/University | Corporate Officer/Principal | |
| University of Colorado Cancer Center | College/University | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 19 |
| Canada | 2 |
| Svizzera | 2 |
| Messico | 2 |
Settori
| Consumer Services | 12 |
| Health Technology | 6 |
| Health Services | 3 |
| Commercial Services | 2 |
Posizioni
| Corporate Officer/Principal | 10 |
| Founder | 9 |
| Director/Board Member | 8 |
| Chief Executive Officer | 5 |
| President | 5 |
Contatti più connessi
| Insiders | |
|---|---|
| Paul Bunn | 10 |
| Richard Duke | 8 |
| Jaime Modiano | 6 |
| Donald Bellgrau | 5 |
| Daniel D. Chan | 1 |
| Lajos Gera | 1 |
- Borsa valori
- Insiders
- John M. Stewart
- Connessioni Società
